Squadron Capital Management »

Inflarx Nv shares owned by Squadron Capital Management

Quarter-by-quarter ownership of Inflarx Nv (IFRX) shares owned by Squadron Capital Management from 13F filings

Historical chart of Squadron Capital Management investment in Inflarx Nv

Tip: Access up to 7 years of quarterly data

All positions including Inflarx Nv held by Squadron Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inflarx Nv by Squadron Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.5M 2.0M 2.24

More positions owned by Squadron Capital Management

Relmada Therapeutics (RLMD)
C4 Therapeutics Com Stk (CCCC)
Cogent Biosciences (COGT)
Zentalis Pharmaceuticals Call Option (ZNTL)
Kodiak Sciences (KOD)
Relay Therapeutics (RLAY)
Edgewise Therapeutics (EWTX)
Maze Therapeatics (MAZE)
Bioage Labs Call Option (BIOA)
Inventiva Sa Ads (IVA)
Adlai Nortye Sponsored Ads (ANL)
Compass Pathways Sponsored Ads (CMPS)
Enliven Therapeutics (ELVN)
Rezolute Com New (RZLT)
Arrivent Biopharma Call Option (AVBP)

View all positions for Squadron Capital Management

Top funds holding Inflarx Nv

Suvretta Capital Management
TCG Crossover Management
FMR
Commodore Capital
Spruce Street Capital
683 Capital Management
Farallon Capital Management
Stempoint Capital
Dr. Jeffrey R. Jay, M.D.
ADAR1 Capital Management
Kalehua Capital Management
Ameriprise Financial
Woodline Partners
Squadron Capital Management
Eversept Partners

View all funds holding Inflarx Nv